Literature DB >> 27075872

After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction.

Akshay S Desai1, Pardeep S Jhund2.   

Abstract

Although patients with heart failure and preserved ejection fraction (HF-PEF) represent nearly half of the population with chronic heart failure, few evidence-based medical therapies are available. The neutral overall results of the TOPCAT trial of spironolactone in HF-PEF leave clinicians who treat heart failure with an ongoing clinical dilemma. In this review, we outline an approach to the clinical management of the patient with HF-PEF synthesizing data from available clinical trials and expert consensus. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Clinical management; Heart failure with preserved ejection fraction; Spironolactone

Mesh：

Substances：

Year:  2016        PMID： 27075872     DOI： 10.1093/eurheartj/ehw114

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


  8 in total

1.  Heart failure with mid-range ejection fraction and with preserved ejection fraction.

Authors:  J Petutschnigg; F Edelmann
Journal:  Herz       Date:  2018-08       Impact factor: 1.443

Review 2.  Contemporary Management of Heart Failure in the Elderly.

Authors:  Joanna Osmanska; Pardeep S Jhund
Journal:  Drugs Aging       Date:  2019-02       Impact factor: 3.923

3.  Current themes in myocardial and coronary vascular aging.

Authors:  Amanda J LeBlanc; Natia Q Kelm; Monika George
Journal:  Curr Opin Physiol       Date:  2017-12-13

4.  [Heart failure with preserved left ventricular ejection fraction].

Authors:  Johannes Petutschnigg; Frank Edelmann
Journal:  Internist (Berl)       Date:  2019-09       Impact factor: 0.743

Review 5.  Primary and Secondary Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.

Authors:  Marco Giuseppe Del Buono; Leo Buckley; Antonio Abbate
Journal:  Am J Cardiol       Date:  2018-08-03       Impact factor: 2.778

6.  Deaths in triathletes: immersion pulmonary oedema as a possible cause.

Authors:  Richard E Moon; Stefanie D Martina; Dionne F Peacher; William E Kraus
Journal:  BMJ Open Sport Exerc Med       Date:  2016-08-29

7.  Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.

Authors:  Claire L Curl; Vennetia R Danes; James R Bell; Antonia J A Raaijmakers; Wendy T K Ip; Chanchal Chandramouli; Tristan W Harding; Enzo R Porrello; Jeffrey R Erickson; Fadi J Charchar; Andrew R Kompa; Amanda J Edgley; David J Crossman; Christian Soeller; Kimberley M Mellor; Jonathan M Kalman; Stephen B Harrap; Lea M D Delbridge
Journal:  J Am Heart Assoc       Date:  2018-06-01       Impact factor: 5.501

Review 8.  Machine Learning for Clinical Decision-Making: Challenges and Opportunities in Cardiovascular Imaging.

Authors:  Sergio Sanchez-Martinez; Oscar Camara; Gemma Piella; Maja Cikes; Miguel Ángel González-Ballester; Marius Miron; Alfredo Vellido; Emilia Gómez; Alan G Fraser; Bart Bijnens
Journal:  Front Cardiovasc Med       Date:  2022-01-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.